Search Results - "Titong, Allison"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2 by Dong, Jianbo, Huang, Betty, Wang, Bo, Titong, Allison, Gallolu Kankanamalage, Sachith, Jia, Zhejun, Wright, Meredith, Parthasarathy, Pannaga, Liu, Yue

    Published in Scientific reports (20-10-2020)
    “…SARS-CoV-2 is a newly emergent coronavirus, which has adversely impacted human health and has led to the COVID-19 pandemic. There is an unmet need to develop…”
    Get full text
    Journal Article
  2. 2

    First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants by Titong, Allison, Gallolu Kankanamalage, Sachith, Dong, Jianbo, Huang, Betty, Spadoni, Nicholas, Wang, Bo, Wright, Meredith, Pham, Keegan L. J., Le, Anh Hai, Liu, Yue

    Published in Scientific reports (09-03-2022)
    “…SARS-CoV-2 and its variants have persisted in this ongoing COVID-19 pandemic. While the vaccines have greatly reduced the COVID-19 cases, hospitalizations, and…”
    Get full text
    Journal Article
  3. 3

    Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity by Dong, Jianbo, Huang, Betty, Jia, Zhejun, Wang, Bo, Gallolu Kankanamalage, Sachith, Titong, Allison, Liu, Yue

    Published in Emerging microbes & infections (01-01-2020)
    “…Coronaviruses cause severe human viral diseases including SARS, MERS and COVID-19. Most recently SARS-CoV-2 virus (causing COVID-19) has led to a pandemic with…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Fc-competent multispecific PDL-1/TIGIT/LAG-3 antibodies potentiate superior anti-tumor T cell response by Yang, Riyao, Huang, Su, Huang, Cai, Fay, Nathan S., Wang, Yanan, Putrevu, Saroja, Wright, Kimberly, Zaman, Mohd Saif, Cai, Wenyan, Huang, Betty, Wang, Bo, Wright, Meredith, Hoag, Matthew R., Titong, Allison, Liu, Yue

    Published in Scientific reports (18-06-2023)
    “…The landscape of current cancer immunotherapy is dominated by antibodies targeting PD-1/PD-L1 and CTLA-4 that have transformed cancer therapy, yet their…”
    Get full text
    Journal Article
  6. 6

    Replication-inducible vaccinia virus vectors with enhanced safety in vivo by O'Connell, Caitlin M, Jasperse, Brittany, Hagen, Caitlin J, Titong, Allison, Verardi, Paulo H

    Published in PloS one (02-04-2020)
    “…Vaccinia virus (VACV) has been used extensively as the vaccine against smallpox and as a viral vector for the development of recombinant vaccines and cancer…”
    Get full text
    Journal Article
  7. 7

    A vaccinia virus renaissance: New vaccine and immunotherapeutic uses after smallpox eradication by Verardi, Paulo H., Titong, Allison, Hagen, Caitlin J.

    Published in Human vaccines & immunotherapeutics (01-07-2012)
    “…In 1796, Edward Jenner introduced the concept of vaccination with cowpox virus, an Orthopoxvirus within the family Poxviridae that elicits cross protective…”
    Get full text
    Journal Article
  8. 8

    Safety mechanism assisted by the repressor of tetracycline (SMART) vaccinia virus vectors for vaccines and therapeutics by Grigg, Patricia, Titong, Allison, Jones, Leslie A., Yilma, Tilahun D., Verardi, Paulo H.

    “…Replication-competent viruses, such as Vaccinia virus (VACV), are powerful tools for the development of oncolytic viral therapies and elicit superior immune…”
    Get full text
    Journal Article
  9. 9

    Abstract LB068: A novel CD20/CD3 T cell engager designed from Rituximab targeting CD20+ cancer with multiple mechanisms by Cai, Wenyan, Dong, Jianbo, Kankanamalage, Sachith Gallolu, Titong, Allison, Shi, Jiadong, Jia, Zhejun, Wang, Bo, Huang, Cai, Zhang, Jing, Lin, Jun, Kan, Steven Z., Zhou, Joe, Liu, Yue

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Background Bispecific T cell engaging antibodies (TEAs) with one arm targeting a cancer antigen and another arm binding to CD3 have demonstrated impressive…”
    Get full text
    Journal Article
  10. 10

    Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication by Hagen, Caitlin J., Titong, Allison, Sarnoski, Ethan A., Verardi, Paulo H.

    Published in Virus research (06-03-2014)
    “…•Uncontrolled replication of vaccinia virus vectors can lead to complications.•We placed early transcription factor genes under the control of tet operon…”
    Get full text
    Journal Article
  11. 11

    Biological activity validation of a computationally designed Rituximab/CD3 T cell engager targeting CD20+ cancers with multiple mechanisms of action by Cai, Wenyan, Dong, Jianbo, Gallolu Kankanamalage, Sachith, Titong, Allison, Shi, Jiadong, Jia, Zhejun, Wang, Bo, Huang, Cai, Zhang, Jing, Lin, Jun, Kan, Steven Z, Han, Shuhua, Zhou, Joe, Liu, Yue

    Published in Antibody therapeutics (01-10-2021)
    “…Abstract Background Bispecific T cell engaging antibodies (TEAs) with one arm targeting a cancer antigen and another arm binding to CD3 have demonstrated…”
    Get full text
    Journal Article
  12. 12

    Development of Repressible Systems to Control Gene Expression in Vaccinia Virus by Titong, Allison

    Published 01-01-2012
    “…Two vaccinia virus (VACV) expression systems that contain elements from the lactose (lac) and the tetracycline (tet) operons of E. coli were developed to…”
    Get full text
    Dissertation